BioSpace News Archive

The CoVIg-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the development of a plasma-derived hyperimmune globulin therapy for COVID-19, is rapidly building momentum.

Sentry Data Systems, Inc., a leader in automated pharmacy procurement, utilization management and 340B compliance, has signed on as a Champion Level Benefactor with nonprofit organization Ryan White Clinics for 340B Access.

Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported financial results for the first quarter ended March 31, 2020 and reviewed business highlights. “We began this year by presenting the first-ever clinical data of its kind, demonstrating that an immunotherapy can prime and boost a strong CD8+ T cell response aga

Company advances mission to combat AML, as this research comes on the heels of its Phase 3 trial, actively enrolling globally

Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced first quarter 2020 financial results and business updates. First Quarter and Recent Highlights Validive Phase 2b/3 Clinical Trial Monopar, in response to the current COVID-19 pandemic and its effe

Rx3000 ® UV Light Air Purifier production shifts to Massachusetts to ensure quality, fast production & delivery Rx3000 inactivates on first pass 99.97% of harmful airborne viruses & bacteria. CDC states UV-C light is one of the most promising methods for Coronavirus (CoV-2) disinfection of face masks. Worcester, MA, May 07, 2020 (GLOBE NEWSWIRE) -- Vystar Corp. (OTCQB: VYST) has shifted to Massachusetts production of its Rx3000 ® , a hybrid ultraviolet (UV)-light air purif

Strata Oncology, a precision oncology company advancing molecular indications for cancer therapies, announced three studies highlighting data featuring its comprehensive genomic profiling assay StrataNGSTM will be presented at the 2020 Annual Meeting of the American Society of Clinical Oncology, taking place digitally from May 29 – May 31.

ArcherDX, Inc. today announced the appointment of Jason Ryan , Chief Operating and Financial Officer at Magenta Therapeutics and former Chief Financial Officer at Foundation Medicine, to the company’s Board of Directors and as the Chair of the Audit Committee.

RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company primarily engaged in sales and distribution of medical devices, announced today that it has successfully completed the independent laboratory testing of its newly

Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed treating patients in its Phase IV clinical tri